Senate to Take on Pharmaceutical Prices Again: Real Reform or More of the Same? – Regulatory Focus


Regulatory Focus
Senate to Take on Pharmaceutical Prices Again: Real Reform or More of the Same?
Regulatory Focus
The Senate has previously targeted particular companies in the pharmaceutical industry with little impact other than to name and shame them. Last year, the Senate Special Aging Committee targeted Turing Pharmaceuticals‘ infamous 5,000% price hike of

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd